Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Inflammatory Bowel Diseases|March 22, 2012
Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel diseaseMona Akbari, Sveta Shah, Fernando S Velayos, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2013
A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximabFernando S Velayos, James G Kahn, William J Sandborn, et al.Gastroenterology|August 21, 2021
AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert ReviewSanjay K Murthy, Joseph D Feuerstein, Geoffrey C Nguyen, et al.The American Journal of Gastroenterology|April 11, 2023
The Contemporary Probability of Occult Colorectal Cancer in Patients With Colitis-Related Dysplasia Undergoing ColectomyEshandeep S Boparai, Jeffrey K Lee, Shiyun Zhu, et al.The American Journal of Gastroenterology|March 9, 2023
Increased Risk of Hospitalization, Surgery, and Venous Thromboembolism Among Patients With Inflammatory Bowel Disease and Malnutrition in a Large, Community-Based Health Care SystemLiat S Fine, Shiyun Zhu, Aida Shirazi, et al.Reviews in Gastroenterological Disorders|May 15, 2008
Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitisGary R Lichtenstein, David T Rubin, Seymour M Sabesin, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 8, 2020
Correction to: Effectiveness of Switching from Reference Product Infliximab to Infliximab-Dyyb in Patients with Inflammatory Bowel Disease in an Integrated Healthcare System in the United States: A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort StudyStephanie L Ho, Fang Niu, Suresh Pola, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 28, 2020
Effectiveness of Switching from Reference Product Infliximab to Infliximab-Dyyb in Patients with Inflammatory Bowel Disease in an Integrated Healthcare System in the United States: A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort StudyStephanie L Ho, Fang Niu, Suresh Pola, et al.The American Journal of Gastroenterology|June 4, 2009
Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylatesJoel H Rubenstein, Akbar K Waljee, Joanne M Jeter, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 8, 2005
The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancerFernando S Velayos, Suk-Hwan Lee, Hongming Qiu, et al.Pageof 5